JMP Securities Lifts Price Target On Oncothyreon (ONTY) to $14
Tweet
Share
E-mailGet Alerts ONTY Hot Sheet
Price: $1.21 --0%
Rating Summary:
7 Buy, 2 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
7 Buy, 2 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Earlier, JMP Securities boosted its price target on Market Outperform-rated Oncothyreon (NASDAQ: ONTY) from $8 to $14.
For an analyst ratings summary and ratings history on Oncothyreon click here. For more ratings news on Oncothyreon click here.
Shares of Oncothyreon are up 1 percent in early trade to $6.29 with a 52 week range of $2.99-$11.59.
For an analyst ratings summary and ratings history on Oncothyreon click here. For more ratings news on Oncothyreon click here.
Shares of Oncothyreon are up 1 percent in early trade to $6.29 with a 52 week range of $2.99-$11.59.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Fiserv (FISV) PT Lowered to $60 at Freedom Broker
- UBS Reiterates Buy Rating on HF Sinclair (DINO)
- Wolverine World Wide (WWW) PT Raised to $31 at UBS on Growth, EPS Upside Potential
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
JMP SecuritiesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
